Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

4.070 +0.010 (+0.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharma

< Previous 1 2 3 4 5 6 7 8 9 Next >
3 Scary COVID Stocks to Avoid
Our Fool roundtable picks three COVID stocks they think are dangerous at these prices. 
Via The Motley Fool
Exposures COVID-19
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
Analyzing Inovio Pharmaceuticals's Unusual Options Activity
Inovio Pharmaceuticals (NASDAQ:INO) shares experienced unus... 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
Apple And Salesforce Lead The DIA In A Mixed Day Of Trading
U.S. indices had a mixed day of trading Thursday as traders and investors weigh COVID-19 variant updates, recent earnings and the recently passed $1 trillion... 
Via Benzinga
Exposures COVID-19
Watch Out: Inovio Pharmaceuticals Is Heating Up
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday alongside other vaccine maker stocks. Stocks have been trading higher recently as the COVIS-19 delta... 
Via Benzinga
Why Inovio Pharmaceuticals Is Plunging Today
Solid business developments did not please investors. 
Via The Motley Fool
Exposures COVID-19
Why Inovio's Stock Is Trading Lower Today
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading lower by 9.9% at $8.65 after the company reported worse-than-expected second-quarter EPS and sales results.... 
Via Benzinga
Inovio Pharmaceuticals (INO) Q2 2021 Earnings Call Transcript
INO earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
85 Biggest Movers From Yesterday
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX... 
Via Benzinga
54 Stocks Moving In Tuesday's Mid-Day Session
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy... 
Via Benzinga
Recap: Inovio Pharmaceuticals Q2 Earnings
Shares of Inovio Pharmaceuticals (NASDAQ:INO) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 95.00% year... 
Via Benzinga
Why Inovio Stock Is Jumping Today
Chinese regulators approved the initiation of two new clinical studies featuring Inovio's COVID-19 vaccine candidate, INO-4800. 
Via The Motley Fool
Exposures COVID-19
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
Via Benzinga
What Does the Delta Variant Mean for Inovio Pharmaceuticals' Stock?
Its vaccine candidate might be too far behind to matter. 
Via The Motley Fool
Exposures COVID-19
Is Inovio Pharmaceuticals Primed For a Comeback?
The past 12 months have been tough on the vaccine maker. 
Via The Motley Fool
Exposures COVID-19
Here's Why Inovio Pharmaceuticals Soared 23% In June
Encouraging news reversed what had been a steep sell-off for the clinical-stage biotech. 
Via The Motley Fool
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021
Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE: 
Via Benzinga
Inovio Pharmaceuticals: Return On Capital Employed Insights
During Q1, Inovio Pharmaceuticals's (NASDAQ:INO) reported sales totaled $371.12 thousand. Despite a 79.13% in earnings, the company posted a loss of $52.55 million. In Q4, Inovio... 
Via Benzinga
Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships
Some say INO stock could be the target of a short squeeze, but Inovio's Covid-19 vaccine program should be a sufficient reason to invest. 
Via InvestorPlace
Exposures COVID-19
Should You Buy Biotech ETFs Now?
Instead of trying to pick winners in this volatile space, it is better to invest in broader biotech ETFs that stand to benefit from increased investor interest and rising spending on drugs and... 
Via Talk Markets
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares... 
Via Benzinga
Why Inovio Stock Is Sinking Today
Investors appear to be taking some profits after yesterday's huge gain. 
Via The Motley Fool
Exposures COVID-19
62 Biggest Movers From Yesterday
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID... 
Via Benzinga
Twitter And Regeneron Lead The SPY In Another Mixed Day Of Trading
U.S. indices at a mixed day of trading Wednesday as investors and traders weighed the U.S. 30-Year Treasury note falling to 2.1483%,... 
Via Benzinga
Why Inovio Stock Looks Ready To Break Out, Make Bullish Reversal
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares were trading higher Wednesday as retail traders continue to push high short interest stocks higher. The stock saw above average... 
Via Benzinga
INO Stock: 2 Big Reasons Inovio Pharmaceuticals Is Shooting Higher Today
Today, INO stock is soaring amid a recently announced expanded partnership for its Covid-19 vaccine and potential short squeeze implications. 
Via InvestorPlace
Exposures COVID-19
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 347.96% to $9.9 during Wednesday's regular session. As of 12:30 EST, Aethlon Medical's stock is... 
Via Benzinga
Inovio Pharmaceuticals Insights: Return On Capital Employed
During Q1, Inovio Pharmaceuticals's (NASDAQ:INO) reported sales totaled $371.12 thousand. Despite a 79.13% in earnings, the company posted a loss of $52.55 million. In Q4, Inovio... 
Via Benzinga
48 Stocks Moving In Wednesday's Mid-Day Session
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares jumped 371% to $10.41 in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.